2 pharmacy CEs* | 2 CEs for CA LAc (approved)
*2 pharmacy CE: approved by CNDA
TUESDAY, June 10th | 6:30 - 8:30 pm
Improving Lifespan and Healthspan
with Menopausal Hormone Therapy
Pharmacy Webinar 59with Kelly Ruef, ND
PW59: Improving Lifespan and Healthspan with Menopausal Hormone Therapy (MHT)
Menopausal hormone therapy (MHT) is a hot topic right now, and for good reason – it has been shown to improve a number of postmenopausal ailments and may even help to prevent bone loss, heart disease, cognitive decline, and dementia in some women. This presentation will not only delve into the evidence behind these claims but will also discuss the importance of choosing the right dose and route of administration, monitoring MHT, and assessing hormone metabolism patterns. Research has shown that estradiol (E2) preparations do not increase patients’ serum E2 levels to the same degree, thus it may be advantageous to monitor E2 therapy to ensure a patient is within the therapeutic range and not being under- or over- dosed. Additionally, physicians can monitor hormone metabolism to decrease the rare risk of breast cancer associated with estrogen therapy and lower potential side effects of MHT.
TUES, June 10th, 2025
6:30 - 8:30pm
Members: $85
Non-members: $105
2 pharmacy CEs
(approved by CNDA)
2 CEs for CA LAc*
(approved)
Category 1 TM Credits | CE Provider #805 | 310 670 8100 | **This course is approved by The California Acupuncture Board for 2 hours of continuing education *Refunds not available
GOALS AND OBJECTIVES
● Understand the evidence showing MHT improves VMS, GSM, VVA, incontinence, UTIs, sleep disturbances, and may prevent bone loss, heart disease, cognitive decline, and dementia.
● Recognize that a patient’s medical history, age and years out from menopause can affect the benefit-risk balance of MHT.
● Understand that every patient is unique and may not respond to (absorb) MHT similarly to the average patient, thus it is important to monitor circulating estradiol levels to ensure optimal patient outcomes.
● Recognize which laboratory methods and tests to use when monitoring EPT.
● Understand how monitoring estrogen metabolites in the urine may help to reduce the rare breast cancer risk associated with MHT and lower potential side effects of MHT.
Dr. Kelly Ruef, ND
Dr. Kelly Ruef is a licensed naturopathic doctor who completed her medical education at the National University of Natural Medicine (NUNM) in Portland, Oregon. She completed a private residency at Pearl Natural Health in downtown Portland, where she specialized in inflammatory bowel diseases and women’s health. For undergraduate education, Dr. Ruef received a Bachelor of Science degree in biochemistry and cell biology with a minor in cognitive neuroscience from the University of California, San Diego (UCSD). She has been a clinical educator for Precision Analytical, makers of the DUTCH Test, since 2019, and played a large role in the development of DUTCH’s newest course, “Introduction to HRT”. She currently speaks on the topics of HRT and laboratory monitoring in hopes that it will lead to improvements in the efficacy and safety of HRT for peri- and postmenopausal women. You can find her on Instagram under @drkellyruef.
